Novo Integrated Sciences Inc. (NASDAQ: NVOS) stock jumped 5.74% on Monday to $0.12 against a previous-day closing price of $0.12. With 21.85 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.44 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $0.1290 whereas the lowest price it dropped to was $0.1185. The 52-week range on NVOS shows that it touched its highest point at $3.32 and its lowest point at $0.10 during that stretch. Beta for the stock currently stands at -0.20.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NVOS was down-trending over the past week, with a drop of -6.16%, but this was down by -44.04% over a month. Three-month performance dropped to -55.93% while six-month performance fell -93.40%. The stock lost -90.65% in the past year, while it has lost -38.64% so far this year.
Float and Shares Shorts:
At present, 29.82 million NVOS shares are outstanding with a float of 12.54 million shares on hand for trading. On Oct 13, 2022, short shares totaled 47890.0, which was 0.15% higher than short shares on Sep 14, 2022. In addition to Mr. Robert Mattacchione as the firm’s Chairman & CEO, Mr. Christopher Mehlin David serves as its COO, Pres & Director.
Through their ownership of 1.37% of NVOS’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 0.65% of NVOS, in contrast to 0.62% held by mutual funds. Shares owned by individuals account for 0.62%. As the largest shareholder in NVOS with 0.73% of the stake, The Vanguard Group, Inc. holds 255,940 shares worth 255,940. A second-largest stockholder of NVOS, RBC Private Counsel, holds 74,943 shares, controlling over 0.21% of the firm’s shares. Geode Capital Management LLC is the third largest shareholder in NVOS, holding 27,693 shares or 0.08% stake. With a 0.50% stake in NVOS, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 174,830 shares are owned by the mutual fund manager. The iShares Tr. – Micro Cap ETF, which owns about 0.07% of NVOS stock, is the second-largest Mutual Fund holder. It holds 25,590 shares valued at 5144.0. Fidelity Nasdaq Composite Index F holds 0.03% of the stake in NVOS, owning 12,127 shares worth 2438.0.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NVOS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded NVOS stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 3 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 10,000 while 0 shares were sold.